376 related articles for article (PubMed ID: 35228752)
21. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
22. Role of the Microbiome in Immunotherapy of Melanoma.
Jiminez V; Yusuf N
Cancer J; 2023 Mar-Apr 01; 29(2):70-74. PubMed ID: 36957976
[TBL] [Abstract][Full Text] [Related]
23. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
Macke L; Schulz C; Koletzko L; Malfertheiner P
Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
[TBL] [Abstract][Full Text] [Related]
24. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma.
Limeta A; Ji B; Levin M; Gatto F; Nielsen J
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268597
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Björk JR; Bolte LA; Maltez Thomas A; Lee KA; Rossi N; Wind TT; Smit LM; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Spector TD; Bataille V; Segata N; Hospers GAP; Weersma RK
Nat Med; 2024 Mar; 30(3):785-796. PubMed ID: 38365950
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
28. The gut microbiome and melanoma: A review.
Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
[TBL] [Abstract][Full Text] [Related]
29. Altitude-adaption of gut microbiota in Tibetan chicken.
Du X; Li F; Kong F; Cui Z; Li D; Wang Y; Zhu Q; Shu G; Tian Y; Zhang Y; Zhao X
Poult Sci; 2022 Sep; 101(9):101998. PubMed ID: 35841636
[TBL] [Abstract][Full Text] [Related]
30. Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis.
Sakurai T; De Velasco MA; Sakai K; Nagai T; Nishiyama H; Hashimoto K; Uemura H; Kawakami H; Nakagawa K; Ogata H; Nishio K; Kudo M
Mol Oncol; 2022 Apr; 16(7):1493-1507. PubMed ID: 34270845
[TBL] [Abstract][Full Text] [Related]
31. Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese Cats.
Ma X; Brinker E; Graff EC; Cao W; Gross AL; Johnson AK; Zhang C; Martin DR; Wang X
Microbiol Spectr; 2022 Jun; 10(3):e0083722. PubMed ID: 35467389
[TBL] [Abstract][Full Text] [Related]
32. Melanoma and microbiota: Current understanding and future directions.
Routy B; Jackson T; Mählmann L; Baumgartner CK; Blaser M; Byrd A; Corvaia N; Couts K; Davar D; Derosa L; Hang HC; Hospers G; Isaksen M; Kroemer G; Malard F; McCoy KD; Meisel M; Pal S; Ronai Z; Segal E; Sepich-Poore GD; Shaikh F; Sweis RF; Trinchieri G; van den Brink M; Weersma RK; Whiteson K; Zhao L; McQuade J; Zarour H; Zitvogel L
Cancer Cell; 2024 Jan; 42(1):16-34. PubMed ID: 38157864
[TBL] [Abstract][Full Text] [Related]
33. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
[TBL] [Abstract][Full Text] [Related]
34. Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age.
Li A; Yang Y; Qin S; Lv S; Jin T; Li K; Han Z; Li Y
Microb Cell Fact; 2021 Mar; 20(1):78. PubMed ID: 33789672
[TBL] [Abstract][Full Text] [Related]
35. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
[TBL] [Abstract][Full Text] [Related]
36. Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events.
Zeng Y; Shi Q; Liu X; Tang H; Lu B; Zhou Q; Xu Y; Chen M; Zhao J; Li Y; Qian J; Wang M; Tan B
Front Oncol; 2023; 13():1144534. PubMed ID: 37114123
[TBL] [Abstract][Full Text] [Related]
37. The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.
Wu Z; Zhang S; Li L; Huang Z; Huang D; Hu Y
Front Oncol; 2022; 12():887383. PubMed ID: 36387171
[TBL] [Abstract][Full Text] [Related]
38. Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation.
Vaitkute G; Panic G; Alber DG; Faizura-Yeop I; Cloutman-Green E; Swann J; Veys P; Standing JF; Klein N; Bajaj-Elliott M
Microbiome; 2022 Jun; 10(1):89. PubMed ID: 35689247
[TBL] [Abstract][Full Text] [Related]
39. The gut microbiota and immune checkpoint inhibitors.
Humphries A; Daud A
Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
[TBL] [Abstract][Full Text] [Related]
40. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
